Patents by Inventor Timothy Brauns

Timothy Brauns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11934055
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: March 19, 2024
    Assignee: Cardinal IG Company
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Publication number: 20240065561
    Abstract: A housing assembly includes a housing body that defines an internal chamber. A connection bracket is located in the internal chamber and includes a first spindle bracket and a second spindle bracket. The first spindle bracket has a first recess and the second spindle bracket has a second recess. A cuff roll assembly includes a first spindle located in the first recess and a second spindle located in the second recess. The first spindle is spaced from the second spindle. A roll of pressure cuffs includes a plurality of pressure cuffs that are sequentially connected and wrapped around the first spindle and the second spindle. The plurality of pressure cuffs each include a first connection strip that is formed of hooks and a second connection strip that is formed of loops. The loops are formed of non-woven polyethylene terephthalate spunlace material.
    Type: Application
    Filed: August 24, 2023
    Publication date: February 29, 2024
    Inventors: Aaron R. Burnham, Megan Mary Burkarski, Carlos Suarez, Timothy Braun, James Cappon
  • Patent number: 11718683
    Abstract: The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated With antigens.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: August 8, 2023
    Assignees: Aperisys, Inc., The General Hospital Corporation
    Inventors: Timothy Brauns, Mark C. Poznansky, Jeffrey A. Gelfand, Huabiao Chen, Stephen J. McCormack
  • Publication number: 20230032677
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Application
    Filed: October 11, 2022
    Publication date: February 2, 2023
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Patent number: 11467439
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: October 11, 2022
    Assignee: Cardinal IG Company
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Patent number: 11135445
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: October 5, 2021
    Assignee: The General Hospital Corporation
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey A. Gelfand, Timothy Brauns
  • Publication number: 20210240031
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 5, 2021
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Patent number: 10989945
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: April 27, 2021
    Assignee: Cardinal IG Company
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Publication number: 20200333656
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Application
    Filed: July 6, 2020
    Publication date: October 22, 2020
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Publication number: 20200323784
    Abstract: The present invention relates to compositions comprising at least one in vitro-developed ?-cell and a CXCL12 polypeptide encapsulated in a microcapsule. The invention further relates to methods for treating diabetes, accelerating the normalization of hyperglycemia, and preventing fibrotic pericapsular overgrowth of microcapsules using transplanted human stem cell-derived ? cells co-encapsulated with a CXCL12 polypeptide.
    Type: Application
    Filed: September 20, 2018
    Publication date: October 15, 2020
    Inventors: Mark Poznansky, David Alagpulinsa, Timothy Brauns
  • Patent number: 10780294
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: September 22, 2020
    Assignee: The General Hospital Corporation
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey Gelfand, Timothy Brauns
  • Patent number: 10705363
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: July 7, 2020
    Assignee: Cardinal IG Company
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Publication number: 20200095332
    Abstract: The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated With antigens.
    Type: Application
    Filed: August 5, 2019
    Publication date: March 26, 2020
    Inventors: Timothy Brauns, Mark C. Poznansky, Jeffrey A. Gelfand, Huabiao Chen, Stephen J. McCormack
  • Publication number: 20190175933
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Application
    Filed: February 15, 2019
    Publication date: June 13, 2019
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
  • Publication number: 20190018277
    Abstract: A privacy glazing structure may include an electrically controllable optically active material that provides controlled transition between a privacy or scattering state and a visible or transmittance state. To make electrical connections with electrode layers that control the optically active material, the privacy glazing structure may include electrode engagement regions. In some examples, the electrode engagement regions are formed as notches in peripheral edges of opposed panes bounding the optically active material. The notches may or may not overlap to provide a through conduit in the region of overlap for wiring. In either case, the notches may allow the remainder of the structure to have a flush edge surface for ease of downstream processing.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 17, 2019
    Inventors: Eric Berner, Eric Bjergaard, Timothy Braun, Andrew DeMiglio, Chad Peters
  • Publication number: 20180036552
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Application
    Filed: November 18, 2015
    Publication date: February 8, 2018
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
  • Patent number: 9803672
    Abstract: A split end tube connector connects fiber reinforced composite tubes, and in particular carbon fiber tubes. The tube connector end inserted into the carbon fiber tube is split lengthwise to alleviate peel stresses caused by thermal contraction of the connector as a result of temperature changes. In a preferred embodiment, the split end tube connector is made from a metal, such as aluminum, steel, or titanium.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: October 31, 2017
    Assignee: ALLRED & ASSOCIATES INC.
    Inventors: Jimmie B. Allred, III, Michael D. Griswold, Timothy Braun
  • Publication number: 20170304400
    Abstract: This disclosure is directed to methods of treating a subject with a fibrotic or fibroproliferative disease, comprising administering to the subject a composition comprising an effective amount of an anti-fibrosis agent, e.g., a CXCR4 and/or CXCR7 binding agent, such as CXCL12.
    Type: Application
    Filed: April 25, 2017
    Publication date: October 26, 2017
    Inventors: Mark Poznansky, James Markmann, Timothy Brauns, Marinko Sremac, Nicolas Chronos, Suren Chavan
  • Patent number: D926128
    Type: Grant
    Filed: March 25, 2020
    Date of Patent: July 27, 2021
    Assignee: WELCH ALLYN, INC.
    Inventors: David G. Perkins, Sean R. Karla, Timothy R. Fitch, David M. Villarreal, Michael Suits, Timothy Braun, Robert S. Englert
  • Patent number: D958735
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: July 26, 2022
    Assignee: WELCH ALLYN, INC.
    Inventors: David G. Perkins, Sean R. Karla, Timothy R. Fitch, David M. Villarreal, Michael Suits, Timothy Braun, Robert S. Englert